Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19

Effects of initiation of programmed-death-protein 1 (PD1) blockade during active SARS-CoV-2 infection on antiviral immunity, COVID-19 course, and underlying malignancy are unclear. We report on the management of a male in his early 40s presenting with highly symptomatic metastatic lung cancer and ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Mellinghoff, Sibylle C., Vanshylla, Kanika, Dahlke, Christine, Addo, Marylyn M., Cornely, Oliver A., Klein, Florian, Persigehl, Thorsten, Rybniker, Jan, Gruell, Henning, Bröckelmann, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721042/
https://www.ncbi.nlm.nih.gov/pubmed/34987520
http://dx.doi.org/10.3389/fimmu.2021.798276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721042/
https://www.ncbi.nlm.nih.gov/pubmed/34987520
http://dx.doi.org/10.3389/fimmu.2021.798276

Ejemplares similares